SCHEMBL4916977

SCHEMBL4916977

Cc1ccc(S(=O)(=O)N(O)C(C(N)=O)C(C)O)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.41
AGER Q15109 1/20 0.41
MAPT P10636 2/20 0.41
POLB P06746 1/20 0.41
ALOX5 P09917 1/20 0.41
MCOLN3 Q8TDD5 1/20 0.40
KEAP1 Q14145 1/20 0.40
NFE2L2 Q16236 1/20 0.40
GAA P10253 1/20 0.40
PLAU P00749 1/20 0.40
F2 P00734 1/20 0.39
PRSS1 P07477 1/20 0.39
PRSS2 P07478 1/20 0.39
PRSS3 P35030 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
SLC1A3 P43003 1/20 0.38
SLC1A2 P43004 1/20 0.38
SLC1A1 P43005 1/20 0.38
KDM4E B2RXH2 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4926951 0.82 CA2 (0.45) ALDH1A1KEAP1NFE2L2GAALMNA
SCHEMBL4926929 0.79 NPC1 (0.45) POLBF2PRSS1PRSS2PRSS3
SCHEMBL3278846 0.78 AGER (0.53) ALDH1A1AGERMAPTPOLBMCOLN3
SCHEMBL4927494 0.76 KEAP1 (0.47) ALDH1A1AGERMAPTPOLBMCOLN3
SCHEMBL5182397 0.75 KEAP1 (0.46) ALDH1A1AGERMAPTMCOLN3KEAP1
SCHEMBL7987856 0.74 MMP9 (0.49) ALDH1A1KEAP1NFE2L2GAAF2
SCHEMBL4928565 0.73 MMP2 (0.45) ALDH1A1ALOX5MEN1KMT2ALMNA
SCHEMBL31195348 0.72 ALDH1A1 (0.50) ALDH1A1AGERMAPTALOX5MCOLN3
SCHEMBL8446570 0.71 CA12 (0.48) ALDH1A1AGERMAPTMCOLN3KEAP1
SCHEMBL8446610 0.71 CA12 (0.48) ALDH1A1AGERMAPTMCOLN3KEAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080269282-A1 Compounds for Inhibiting Copper-Containing Amine Oxidases and Uses Thereof GENMEDICA THERAPEUTICS SL (ES) 2008-10-30 US claimed
US-20070066646-A1 Compounds for Inhibiting Copper-Containing Amine Oxidases and Uses Thereof GENMEDICA THERAPEUTICS SL (ES) 2007-03-22 US claimed
US-20070066646-A1 Compounds for Inhibiting Copper-Containing Amine Oxidases and Uses Thereof GENMEDICA THERAPEUTICS SL (ES) 2007-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080269282-A1 Compounds for Inhibiting Copper-Containing Amine Oxidases and Uses Thereof AOC2, AOC3, AOC1 ALDH1A1 28/4885AGER 73/4885MAPT 294/4885
US-20070066646-A1 Compounds for Inhibiting Copper-Containing Amine Oxidases and Uses Thereof AOC2, AOC3, AOC1 ALDH1A1 27/4885AGER 83/4885MAPT 275/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.